Dr. Arulandu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6923 W 400 N
Michigan City, IN 46360Phone+1 219-326-1234Fax+1 219-879-1401
Summary
- Joseph R Arulandu, MD, FACP is a triple board certified internist/ cardiorenal metabolic syndrome specialist in northwest Indiana. He received his MD from Ross University School of Medicine and has been in practice over 22 years. He has extensive experience in cardiovascular/ renal disease prevention, diabetes, obesity, and complex lipids. He manages diet and exercises lifestyle choices.
Education & Training
- Northeast Ohio University College of Medicine AffiliatesResidency, Internal Medicine, 1998 - 2001
- Ross University School of MedicineClass of 1998
Certifications & Licensure
- IN State Medical License 2001 - 2025
- OH State Medical License 1999 - 2003
- IL State Medical License 2001 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Obesity Medicine Obesity Medicine
- American Board of Clinical LipidologyCardiovascular Disease
Awards, Honors, & Recognition
- Diabetes Recognition Program National Committee for Quality Assurance, 2010-2013
- LaPorte Hospital Staff “Star Performer” 2005
- LaPorte Hospital Staff “Star Performer”- “Outstanding Physician" (2002), 2003
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsInsulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?Vanita R. Aroda, Joseph R. Arulandu, Anthony J. Cannon
Clinical Diabetes. 2018-04-01
Journal Articles
- New Treatments for Alzheimer’s Disease.Arulandu JR, Internal Medicine World Report 2004;19:22
- New Therapies for Benign Prostatic Hypertrophy.Arulandu JR, Internal Medicine World Report 2004;19:13
- New Treatment Options for Treating ED.Arulandu JR, Internal Medicine World Report 2003;18:17
- Join now to see all
Lectures
- Risk Factors for Heart Disease.Purdue-NorthCentral University Faculty
- Aggressive Treatment of Hypertension and Dyslipidemia in Prevention of Coronary Artery Disease and Stroke.5th Annual Primary Care Update- Michigan State University
- Heart Healthy for 2005.Medical Education Conference,LaPorte Hospital
- Join now to see all
Press Mentions
- ‘I Took Ozempic off Label + Then Looked into the Science’December 26th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: